These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 18991824)

  • 41. Confusing messages from the newest of the beta-blocker/diuretic hypertension trials. The Metoprolol Atherosclerosis Prevention in Hypertensives trial.
    Moser M; Sheps S
    Arch Intern Med; 1989 Oct; 149(10):2174-5. PubMed ID: 2572204
    [No Abstract]   [Full Text] [Related]  

  • 42. Sleep quality in patients with hypertension: additional negative effect of drug therapy.
    Yontar OC; Erdem A; Yilmaz MB
    Sleep Med; 2009 Dec; 10(10):1168; author reply 1168-9. PubMed ID: 19467925
    [No Abstract]   [Full Text] [Related]  

  • 43. Metoprolol succinate extended release/hydrochlorothiazide combination tablets.
    Hainer JW; Sugg J
    Vasc Health Risk Manag; 2007; 3(3):279-88. PubMed ID: 17703635
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Atenolol or metoprolol as beta-blocker in the treatment of hypertension].
    van den Born BJ; Brewster LM; Koopmans RP; van Montfrans GA
    Ned Tijdschr Geneeskd; 2005 Aug; 149(32):1808-9. PubMed ID: 16121668
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Beta-blockers are safe in patients with chronic obstructive pulmonary disease, but only with caution.
    Cazzola M; Matera MG
    Am J Respir Crit Care Med; 2008 Oct; 178(7):661-2. PubMed ID: 18796649
    [No Abstract]   [Full Text] [Related]  

  • 46. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
    J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Complex assessment of efficacy and tolerance of metoprolol CR/ZOK in treating hypertension].
    Podzolkov VI; Strizhakov LA; Pavlov VI; Makolkin VI
    Ter Arkh; 2002; 74(11):74-7. PubMed ID: 12498136
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative effectiveness of beta-adrenergic antagonists (atenolol, metoprolol tartrate, carvedilol) on the risk of rehospitalization in adults with heart failure.
    Go AS; Yang J; Gurwitz JH; Hsu J; Lane K; Platt R
    Am J Cardiol; 2007 Aug; 100(4):690-6. PubMed ID: 17697830
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Carvedilol or sustained-release metoprolol for congestive heart failure: a comparative effectiveness analysis.
    Shore S; Aggarwal V; Zolty R
    J Card Fail; 2012 Dec; 18(12):919-24. PubMed ID: 23207080
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The COMET study compares effect of two different beta-blockers in chronic heart failure. Carvedilol better than metoprolol].
    Swedberg K
    Lakartidningen; 2003 Sep; 100(37):2852-4. PubMed ID: 14558169
    [No Abstract]   [Full Text] [Related]  

  • 51. Switching to once-daily evidence-based [beta]-blockers in patients with systolic heart failure or left ventricular dysfunction after myocardial infarction.
    Albert NM
    Crit Care Nurse; 2007 Dec; 27(6):62-72. PubMed ID: 18032686
    [No Abstract]   [Full Text] [Related]  

  • 52. Metoprolol CR/ZOK--its role and efficacy: a review article.
    Kendall M
    J Clin Pharmacol; 1990 Feb; 30(S2):S57-60. PubMed ID: 2179281
    [No Abstract]   [Full Text] [Related]  

  • 53. Long-term treatment with low-dose metoprolol CR/XL is associated with increased plaque echogenicity: the Beta-blocker Cholesterol-lowering Asymptomatic Plaque Study (BCAPS).
    Ostling G; Gonçalves I; Wikstrand J; Berglund G; Nilsson J; Hedblad B
    Atherosclerosis; 2011 Apr; 215(2):440-5. PubMed ID: 21315352
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metoprolol, a beta-1 selective blocker, can be used safely in coronary artery disease patients with chronic obstructive pulmonary disease.
    Camsari A; Arikan S; Avan C; Kaya D; Pekdemir H; Ciçek D; Kiykim A; Sezer K; Akkuş N; Alkan M; Aydoğdu S
    Heart Vessels; 2003 Sep; 18(4):188-92. PubMed ID: 14520486
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of nebivolol and metoprolol treatments on serum asymmetric dimethylarginine levels in hypertensive patients with type 2 diabetes mellitus.
    Oğuz A; Uzunlulu M; Yorulmaz E; Yalçin Y; Hekim N; Fici F
    Anadolu Kardiyol Derg; 2007 Dec; 7(4):383-7. PubMed ID: 18065333
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metoprolol succinate vs. ivabradine in the treatment of inappropriate sinus tachycardia in patients unresponsive to previous pharmacological therapy.
    Ptaszynski P; Kaczmarek K; Ruta J; Klingenheben T; Wranicz JK
    Europace; 2013 Jan; 15(1):116-21. PubMed ID: 22772053
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Practical approaches to selection of beta-adrenoblocker for the treatment of cardiovascular diseases: novel evidence based data].
    Giliarevskiĭ SR
    Kardiologiia; 2006; 46(11):79-85. PubMed ID: 17183752
    [No Abstract]   [Full Text] [Related]  

  • 58. Management of cocaine-associated chest pain.
    Fayomi O
    Emerg Med J; 2009 Oct; 26(10):760. PubMed ID: 19773516
    [No Abstract]   [Full Text] [Related]  

  • 59. Beta Blockade in Cardiovascular Disease: Current Perspectives on Patient Protection. Symposium proceedings. New Orleans, Louisiana, November 10, 1996.
    Am J Cardiol; 1997 Nov; 80(9B):1J-58J. PubMed ID: 9412242
    [No Abstract]   [Full Text] [Related]  

  • 60. Research into "real world" older patients is needed.
    Cunningham CJ
    BMJ; 2016 Jun; 353():i3136. PubMed ID: 27268071
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.